ESR1 and cancer: In all the ERα-positive studied models, treatment with E2 induced important transcriptional changes, mostly by modulating genes associated with oncogenic pathways such as MYC and mTORC1, and promoted cancer cell metabolism, notably by increasing the expression of genes involved in mitochondrial respiration.